背景:化脓性汗腺炎(HS)是一种与肥胖高度相关的慢性炎症性疾病。结合珠蛋白血清水平最近被认为是将肥胖与慢性炎症联系起来的重要生物标志物。
目的:比较触珠蛋白与先前提出的血清生物标志物,以确定HS患者的疾病严重程度。为此,HS患者的疾病严重程度由一组临床评分以及几个危险因素决定,比如体重和吸烟习惯。
方法:前瞻性,在波鸿国际化脓性汗腺炎/痤疮中心(ICH)进行了诊断准确性研究.该研究共纳入263例患者,包括131名HurleyI确诊为HS的患者(n=16),II(n=56),和III(n=59)HS,和132个健康对照。主要结果是确定HS疾病严重程度的血清学炎症标志物[严重(III)与中度/轻度(II/I)]通过Hurley分类评估。
结果:急性时相蛋白结合珠蛋白和CRP,以及外周血中嗜中性粒细胞的数量,单核细胞的数量,根据已建立的临床评分,全身免疫炎症指数和泛免疫炎症值与疾病严重程度相关(mHSS,SAHS,Hurley,DLQI)。与健康对照相比,HS患者的haptologlobin水平明显更高。Logistic回归分析显示触珠蛋白是预测严重HS的唯一独立标志物。
结论:在这项前瞻性研究中,我们发现血清急性期蛋白结合珠蛋白水平可作为HS疾病严重程度的独立标志.这是在HS背景下的第一项研究。因此,目前的数据不仅产生了一个非常有希望的血清标记,进一步验证。
BACKGROUND: Hidradenitis suppurativa (HS) is a chronic inflammatory disease that is highly correlated with obesity. Haptoglobin serum levels have recently been recognized as an important biomarker linking obesity with chronic inflammation.
OBJECTIVE: To compare haptoglobin with previously proposed serum biomarkers for the determination of disease severity in HS patients. For this purpose, disease severity of HS patients was determined by a panel of clinical scores as well as several risk factors, such as weight and smoking habits.
METHODS: A prospective, diagnostic accuracy
study was performed at the International Centre for Hidradenitis suppurativa/Acne inversa Bochum (ICH). The
study included a total of 263 patients, including 131 who had a confirmed diagnosis of HS in Hurley I (n = 16), II (n = 56) and III (n = 59) HS, and 132 healthy controls. The main outcome was to identify serological inflammatory markers for HS disease severity [severe (III) vs. moderate/mild (II/I)] as assessed by Hurley classification.
RESULTS: The serum levels of acute phase proteins haptoglobin and CRP, as well as the number of neutrophils in peripheral blood, number of monocytes, the systemic immune-inflammation index and the pan-immune-inflammatory value correlated with disease severity according to established clinical scores (mHSS, SAHS, Hurley, DLQI). HS patients had significantly higher haptologlobin levels compared to healthy controls. Logistic regression analysis revealed haptoglobin as the only independent marker predicting severe HS.
CONCLUSIONS: In this prospective
study, we discovered that the serum levels of the acute phase protein haptoglobin levels serve as an independent marker of disease severity in HS. While this presents the first
study in the context of HS. Thus, the present data not only yield a highly promising serum marker to be further validated.